Skip to main content

BROWN FORMAN CORP

For the period ended Apr 30, 2024. Filed Jun 14, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Jun 14, 2024

BF-A$31.28-0.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Notes to Consolidated Financial Statements

(Dollars and other currency amounts in millions, except per share data)

  1. Accounting Policies

We prepare our consolidated financial statements in conformity with accounting principles generally accepted in the United States (GAAP). We also apply the following accounting policies when preparing our consolidated financial statements:

Principles of consolidation. Our consolidated financial statements include the accounts of all subsidiaries in which we have a controlling financial interest. We use the equity method to account for investments in entities that we do not control but over whose operating and financial policies we have the ability to exercise significant influence. We eliminate all intercompany transactions.

Estimates. To prepare financial statements that conform with GAAP, our management must make informed estimates that affect how we report revenues, expenses, assets, and liabilities, including contingent assets and liabilities. Actual results could differ from these estimates.

Cash equivalents. Cash equivalents include bank demand deposits and all highly liquid investments with original maturities of three months or less.

Accounts receivable. Accounts receivable are recorded net of an allowance for expected credit losses (allowance for doubtful accounts). We determine the allowance using information such as customer credit history and financial condition, historical loss experience, and macroeconomic factors. We write off account balances against the allowance when we have exhausted our collection efforts. The allowance for doubtful accounts was $7 and $8 at April 30, 2023 and 2024, respectively.

Inventories. Inventories are valued at the lower of cost or net realizable value. Approximately 49% of our consolidated inventories are valued using the last-in, first-out (LIFO) cost method, which we use for the majority of our U.S. inventories. We value the remainder of our inventories primarily using the first-in, first-out (FIFO) cost method. FIFO cost approximates current replacement cost. If we had used the FIFO method for all inventories, they would have been $429 and $512 higher than reported at April 30, 2023 and 2024, respectively.

Because we age most of our whiskeys in barrels for three years or more, we bottle and sell only a portion of our whiskey inventory each year. Following industry practice, we classify all barreled whiskey as a current asset. We include warehousing, insurance, ad valorem taxes, and other carrying charges applicable to barreled whiskey in inventory costs.

We classify agave inventories, bulk tequila, barreled rum, and liquid in bottling tanks as work in process.

Property, plant, and equipment. We state property, plant, and equipment at cost less accumulated depreciation. We calculate depreciation on a straight-line basis using our estimates of useful life, which are 20–40 years for buildings and improvements;3–10 years for machinery, equipment, vehicles, furniture, and fixtures; and 3–7 years for capitalized software.

We assess our property, plant, and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of those assets may not be recoverable. When we do not expect to recover the carrying value of an asset (or asset group) through undiscounted future cash flows, we write it down to its estimated fair value. We determine fair value using discounted estimated future cash flows, considering market values for similar assets when available.

When we retire or dispose of property, plant, and equipment, we remove its cost and accumulated depreciation from our balance sheet and reflect any gain or loss in operating income. We expense the costs of repairing and maintaining our property, plant, and equipment as we incur them.

Goodwill and other intangible assets. When we acquire a business, we first allocate the purchase price to identifiable assets and liabilities, including intangible brand names and trademarks (“brand names”), based on estimated fair value. We then record any remaining purchase price as goodwill. We do not amortize goodwill or other intangible assets with indefinite lives. We consider all of our brand names to have indefinite lives.

We assess our goodwill and other indefinite-lived intangible assets for impairment at least annually, or more frequently if circumstances indicate the carrying amount may be impaired. Goodwill is impaired when the carrying amount of the related reporting unit exceeds its estimated fair value, in which case we write down the goodwill by the amount of the excess (limited to the carrying amount of the goodwill). We estimate the reporting unit's fair value using discounted estimated future cash flows or market information. Similarly, a brand name is impaired when its carrying amount exceeds its estimated fair value, in which case we write down the brand name to its estimated fair value. We estimate the fair value of a brand name using the relief-from- royalty method. We also consider market values for similar assets when available. Considerable management judgment is necessary to estimate fair value, including the selection of assumptions about future cash flows, net sales, discount rates, and royalty rates.

We have the option, before quantifying the fair value of a reporting unit or brand name, to evaluate qualitative factors to assess whether it is more likely than not that our goodwill or brand names are impaired. If we determine that is not the case, then we are not required to quantify the fair value. That assessment also takes considerable management judgment.

Revenue recognition. Our net sales predominantly reflect global sales of beverage alcohol consumer products. We sell these products under contracts with different types of customers, depending on the market. The customer is most often a distributor, wholesaler, or retailer.

Each contract typically includes a single performance obligation to transfer control of the products to the customer. Depending on the contract, control is transferred when the products are either shipped or delivered to the customer, at which point we recognize the transaction price for those products as net sales. The transaction price recognized at that point reflects our estimate of the consideration to be received in exchange for the products. The actual amount may ultimately differ due to the effect of various customer incentives and trade promotion activities. In making our estimates, we consider our historical experience and current expectations, as applicable. Subsequent adjustments recognized for changes in estimated transaction prices are typically not material.

Net sales exclude taxes we collect from customers that are imposed by various governments on our sales, and are reduced by payments to customers unless made in exchange for distinct goods or services with fair values approximating the payments. Net sales include any amounts we bill customers for shipping and handling activities related to the products. We recognize the cost of those activities in cost of sales during the same period in which we recognize the related net sales. Sales returns, which are permitted only in limited situations, are not material. Customer payment terms generally range from 30 to 90 days. There are no significant amounts of contract assets or liabilities.

Cost of sales. Cost of sales includes the costs of receiving, producing, inspecting, warehousing, insuring, and shipping goods sold during the period.

Advertising costs. We expense the production costs of advertising when the advertisements first take place. We expense all other advertising costs during the year in which the costs are incurred.

Selling, general, and administrative expenses. Selling, general, and administrative expenses include the costs associated with our sales force, administrative staff and facilities, and other expenses related to our non-manufacturing functions.

Stock-based compensation. We use stock-based awards as part of our incentive compensation for eligible employees and directors. We recognize the grant-date fair value of an award as compensation expense on a straight-line basis over the requisite service period, which typically corresponds to the vesting period for the award. Upon forfeiture of an award prior to vesting, we reverse any previously recognized compensation expense related to that award. We classify stock-based compensation expense within selling, general, and administrative expenses.

As we recognize compensation expense for a stock-based award, we concurrently recognize a related deferred tax asset. The subsequent vesting or exercise of the award will generally result in an actual tax benefit that differs from the deferred tax asset that had been recorded. The excess (deficiency) of the actual tax benefit over (under) the previously recorded tax asset is recognized as income tax benefit (expense) on the date of vesting or exercise.

Income taxes. We base our annual provision for income taxes on the pre-tax income reflected in our consolidated statement of operations. We establish deferred tax liabilities or assets for temporary differences between GAAP and tax reporting bases and later adjust them to reflect changes in tax rates expected to be in effect when the temporary differences reverse. We record a valuation allowance as necessary to reduce a deferred tax asset to the amount that we believe is more likely than not to be realized. We do not provide deferred income taxes on undistributed earnings of foreign subsidiaries that we expect to indefinitely reinvest. We record a deferred tax charge in prepaid taxes for the difference between GAAP and tax reporting bases with respect to the elimination of intercompany profit in ending inventory.

We assess our uncertain income tax positions in two steps. First, we evaluate whether the tax position will more likely than not, based on its technical merits, be sustained upon examination, including resolution of any related appeals or litigation. For a tax position that does not meet this first criterion, we recognize no tax benefit. For a tax position that does meet the first criterion, we recognize a tax benefit in an amount equal to the largest amount of benefit that we believe has more than a 50% likelihood of being realized upon ultimate resolution. We record interest and penalties on uncertain tax positions as income tax expense.

Foreign currency transactions and translation. We report all gains and losses from foreign currency transactions (those denominated in a currency other than the entity's functional currency) in current income. The U.S. dollar is the functional currency for most of our consolidated entities. The local currency is the functional currency for some of our consolidated foreign entities. We translate the financial statements of those foreign entities into U.S. dollars, using the exchange rate in effect at the balance sheet date to translate assets and liabilities, and using the average exchange rate for the reporting period to translate income and expenses. We record the resulting translation adjustments in other comprehensive income (loss).

Accounting standards not yet adopted. In November 2023, the Financial Accounting Standards Board (FASB) issued an updated accounting standard requiring additional disclosures about significant segment expenses and other segment items. The update also requires interim disclosure of segment information that is currently required only on an annual basis. We are required to adopt the updated standard for annual disclosures beginning in fiscal 2025, and for interim disclosures in fiscal 2026, with earlier adoption permitted. The update is to be applied retroactively.

In December 2023, FASB issued an updated accounting standard requiring additional disclosures about income taxes, primarily related to the rate reconciliation and information about income taxes paid. We are required to adopt the new guidance beginning in fiscal 2026, with earlier adoption permitted. The update can be applied either prospectively or retrospectively.

We are currently evaluating the impact that adopting these accounting standards updates will have on our disclosures.

  1. Balance Sheet Information

Supplemental information on our year-end balance sheets is as follows:

April 30,20232024
Other current assets:
Prepaid taxes$122$100
Other167165
$289$265
Property, plant, and equipment:
Land$97$49
Buildings717782
Equipment889928
Construction in process217181
1,9201,940
Less accumulated depreciation889866
$1,031$1,074
Accounts payable and accrued expenses:
Accounts payable, trade$308$267
Accrued expenses:
Advertising, promotion, and discounts216200
Compensation and commissions106105
Excise and other non-income taxes7667
Other121154
519526
$827$793
Other liabilities:
Contingent consideration$63$69
Other190174
$253$243
Accumulated other comprehensive income (loss), net of tax:
Currency translation adjustments$(104)$(111)
Cash flow hedge adjustments1010
Postretirement benefits adjustments(141)(120)
$(235)$(221)
  1. Earnings per Share

We calculate basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share further includes the dilutive effect of stock-based compensation awards. We calculate that dilutive effect using the “treasury stock method” (as defined by GAAP).

The following table presents information concerning basic and diluted earnings per share:

202220232024
Net income available to common stockholders$838$783$1,024
Share data (in thousands):
Basic average common shares outstanding478,879479,155476,394
Dilutive effect of stock-based awards1,6861,310826
Diluted average common shares outstanding480,565480,465477,220
Basic earnings per share$1.75$1.63$2.15
Diluted earnings per share$1.74$1.63$2.14

We excluded common stock-based awards for approximately 691,000 shares,1,107,000 shares, and 1,689,000 shares from the calculation of diluted earnings per share for 2022, 2023, and 2024, respectively, because they were not dilutive for those periods under the treasury stock method.

  1. Goodwill and Other Intangible Assets

The following table shows the changes in goodwill (which include no accumulated impairment losses) and other intangible assets over the past two years:

GoodwillOther Intangible Assets
Balance as of April 30, 2022$761$586
Business acquisitions (Note 13)652619
Foreign currency translation adjustment4455
Impairment—(96)
Balance as of April 30, 20231,4571,164
Purchase accounting adjustments (Note 13)40(53)
Business divestitures (Note 14)(28)(89)
Foreign currency translation adjustment(14)(25)
Impairment—(7)
Balance as of April 30, 2024$1,455$990

Our other intangible assets consist of trademarks and brand names, all with indefinite useful lives.

During fiscal 2023, we recognized a non-cash impairment charge of $96 for the Finlandia brand name, largely reflecting the effects of higher discount rates and input costs on its valuation. During fiscal 2024, we recorded a $7 impairment charge related to the write-off of the carrying amount of an immaterial discontinued brand name. The impairment charges are included in “other expense (income), net” in the accompanying consolidated statements of operations.

  1. Equity Method Investments

As of April 30, 2024, our equity method investments include a 21.4% ownership of the common stock of The Duckhorn Portfolio, Inc. (“Duckhorn”), which we obtained as partial consideration for the sale of the Sonoma-Cutrer wine business to Duckhorn (Note 14). The $267 carrying amount of the investment reflects the fair value of the common stock, based on its quoted market price at the April 30, 2024 closing date of the transaction. As of April 30, 2024, the difference between the carrying amount of the investment and our proportionate share of the net assets of Duckhorn was not material.

Our other equity method investments are immaterial.

  1. Contingencies

We operate in a litigious environment, and we are sued in the normal course of business. Sometimes plaintiffs seek substantial damages. Significant judgment is required in predicting the outcome of these suits and claims, many of which take years to adjudicate. We accrue estimated costs for a contingency when we believe that a loss is probable and we can make a reasonable estimate of the loss, and then adjust the accrual as appropriate to reflect changes in facts and circumstances. We do not believe it is reasonably possible that these existing loss contingencies, individually or in the aggregate, would have a material adverse effect on our financial position, results of operations, or liquidity. No material accrued loss contingencies are recorded as of April 30, 2024.

  1. Debt and Credit Facilities

Our long-term debt (net of unamortized discounts and issuance costs) consisted of:

April 30,20232024
3.50% senior notes, $300 principal amount, due April 15, 2025$299$300
1.20% senior notes, €300 principal amount, due July 7, 2026330321
2.60% senior notes, £300 principal amount, due July 7, 2028375375
4.75% senior notes, $650 principal amount, due April 15, 2033642643
4.00% senior notes, $300 principal amount, due April 15, 2038295295
3.75% senior notes, $250 principal amount, due January 15, 2043248248
4.50% senior notes, $500 principal amount, due July 15, 2045489490
2,6782,672
Less current portion—300
$2,678$2,372

Debt payments required over the next five fiscal years consist of $300 in 2025, $0 in 2026, $322 in 2027, $0 in 2028, $377 in 2029, and $1,700 after 2029.

The senior notes contain terms, events of default, and covenants customary of these types of unsecured securities, including limitations on the amount of secured debt we can issue.

Details of our short-term borrowings at April 30, 2023 and 2024, are presented below:

April 30,20232024
Commercial paper (par amount)$235$429
Average interest rate5.17%5.49%
Average remaining days to maturity2112

We have a committed revolving credit agreement with various U.S. and international banks for $900 that expires in May 2028. At April 30, 2024, there were no borrowings outstanding under this facility.

  1. Common Stock

The following table shows the change in outstanding common shares during each of the last three years:

(Shares in thousands)Class AClass BTotal
Balance at April 30, 2021169,110309,619478,729
Stock issued under compensation plans65226291
Balance at April 30, 2022169,175309,845479,020
Stock issued under compensation plans65231296
Balance at April 30, 2023169,240310,076479,316
Acquisition of treasury stock(176)(6,736)(6,912)
Stock issued under compensation plans44152196
Balance at April 30, 2024169,108303,492472,600
  1. Net Sales

The following table shows our net sales by geography:

202220232024
United States$1,917$1,968$1,889
Developed International11,1371,1831,158
Emerging2714842886
Travel Retail3104147158
Non-branded and bulk4618887
$3,933$4,228$4,178

1 Represents net sales of branded products to “advanced economies” as defined by the International Monetary Fund (IMF), excluding the United States. Our top developed international markets are Germany, Australia, the United Kingdom, France, Canada, and Spain.

2 Represents net sales of branded products to “emerging and developing economies” as defined by the IMF. Our top emerging markets are Mexico, Poland, and Brazil.

3 Represents net sales of branded products to global duty-free customers, other travel retail customers, and the U.S. military, regardless of customer location.

4 Includes net sales of used barrels, contract bottling services, and non-branded bulk whiskey and wine, regardless of customer location.

The following table shows our net sales by product category:

202220232024
Whiskey1$2,756$2,915$2,832
Ready-to-Drink2431509520
Tequila3290320306
Wine4219206205
Vodka51099982
Non-branded and bulk6618887
Rest of portfolio76791146
$3,933$4,228$4,178

1 Includes all whiskey spirits and whiskey-based flavored liqueurs. The brands included in this category are the Jack Daniel’s family of brands (excluding the “ready-to-drink” products outlined below), the Woodford Reserve family of brands, the Old Forester family of brands, The Glendronach, Glenglassaugh, Benriach, Slane Irish Whiskey, and Coopers’ Craft.

2 Includes the Jack Daniel’s ready-to-drink (RTD) and ready-to-pour (RTP) products, New Mix, and other RTD/RTP products.

3 Includes el Jimador, the Herradura family of brands, and other tequilas.

4 Includes Korbel California Champagne and Sonoma-Cutrer wines (which was divested on April 30, 2024).

5 Includes Finlandia Vodka (which was divested on November 1, 2023). Net sales for the second half of fiscal 2024 were recognized pursuant to the transition services agreement related to distribution services in certain markets.

6 Includes net sales of used barrels, contract bottling services, and non-branded bulk whiskey and wine.

7 Includes Diplomático, Chambord, Gin Mare, Korbel Brandy, and Fords Gin.

  1. Pension and Other Postretirement Benefits

We sponsor various defined benefit pension plans as well as postretirement plans providing retiree health care and retiree life insurance benefits. Below, we discuss our obligations related to these plans, the assets dedicated to meeting the obligations, and the amounts we recognized in our financial statements as a result of sponsoring these plans.

Obligations. We provide eligible employees with pension and other postretirement benefits based on factors such as years of service and compensation level during employment. The pension obligation shown below (“projected benefit obligation”) consists of: (a) benefits earned by employees to date based on current salary levels (“accumulated benefit obligation”); and (b) benefits to be received by employees as a result of expected future salary increases. (The obligation for medical and life insurance benefits is not affected by future salary increases.)The following table shows how the present value of our projected benefit obligations changed during each of the last two years.

Pension BenefitsMedical and LifeInsurance Benefits
2023202420232024
Obligation at beginning of year$846$731$43$40
Service cost20181—
Interest cost323412
Net actuarial loss (gain)1(21)(61)(2)(3)
Retiree contributions——23
Benefits paid(146)(44)(5)(6)
Obligation at end of year$731$679$40$36

1 The net actuarial loss (gain) during each year was primarily attributable to changes in discount rates.

Service cost represents the present value of the benefits attributed to service rendered by employees during the year. Interest cost is the increase in the present value of the obligation due to the passage of time. Net actuarial loss (gain) is the change in value of the obligation resulting from experience different from that assumed or from a change in an actuarial assumption. (We discuss actuarial assumptions used at the end of this note.) Plan amendments can also change the value of the obligation.

As shown in the previous table, the change in the value of our pension and other postretirement benefit obligations also includes the effect of benefit payments and retiree contributions. Expected benefit payments (net of retiree contributions) over the next 10 years are as follows:

Pension Benefits · Medical and LifeInsurance Benefits
2025$54$3
2026543
2027553
2028563
2029573
2030 – 203428614

Assets. We invest in specific assets to fund our pension benefit obligations. Our investment goal is to earn a total return that, over time, will grow assets sufficiently to fund our plans' liabilities, after providing appropriate levels of contributions and accepting prudent levels of investment risk. To achieve this goal, plan assets are invested primarily in funds or portfolios of funds managed by outside managers. Investment risk is managed by company policies that require diversification of asset classes, manager styles, and individual holdings. We measure and monitor investment risk through quarterly and annual performance reviews, and through periodic asset/liability studies.

Asset allocation is the most important method for achieving our investment goals and is based on our assessment of the plans' long-term return objectives and the appropriate balances needed for liquidity, stability, and diversification. As of April 30, 2024, our target asset allocation is a mix of 26% public equity investments,59% fixed income investments, and 15% alternative investments.

The following table shows the fair value of pension plan assets by category as of the end of the last two years. (Fair value levels are defined in Note 16.)

Level 1Level 2Level 3Total
Equity securities$35$—$—$35
Cash and temporary investments2——2
Limited partnership interest1——11
$37$—$138
Investments measured at net asset value:
Commingled trust funds2:
Equity funds138
Fixed income funds330
Real estate fund59
Short-term investments2
Limited partnership interests339
Total$606
Equity securities$31$—$—$31
Fixed income investments—278—278
Limited partnership interest1——11
Pending transactions(3)——(3)
$28$278$1307
Investments measured at net asset value:
Commingled trust funds2:
Equity funds118
Fixed income funds53
Real estate fund49
Short-term investments11
Limited partnership interests338
Total$576

1 This limited partnership interest was initially valued at cost and has been adjusted to fair value as determined in good faith by management of the partnership using various factors, and does not meet the requirements for reporting at the net asset value (NAV). The valuation requires significant judgment due to the absence of quoted market prices and the inherent lack of liquidity. This limited partnership has a term expiring in September 2024.

2 Commingled trust fund valuations are based on the NAV of the funds as determined by the fund administrators and reviewed by us. NAV represents the underlying assets owned by the fund, minus liabilities and divided by the number of shares or units outstanding. Generally, for commingled trust funds other than real estate, redemptions are permitted daily with no notice period. The real estate fund is redeemable quarterly with 110 days' notice.

3 These limited partnership interests were initially valued at cost and have been adjusted using NAV per audited financial statements. Investments are generally not eligible for immediate redemption and have original terms averaging 10 to 13 years, although those periods may be extended.

The following table shows how the fair value of the Level 3 assets changed during each of the last two years. There were no transfers of assets between Level 3 and either of the other two levels.

Level 3
Balance as of April 30, 2022$2
Return on assets held at end of year(1)
Balance as of April 30, 20231
Return on assets held at end of year—
Balance as of April 30, 2024$1

The following table shows how the total fair value of all pension plan assets changed during each of the last two years. (We do not have assets set aside for postretirement medical or life insurance benefits.)

Pension BenefitsMedical and LifeInsurance Benefits
2023202420232024
Assets at beginning of year$741$606$—$—
Actual return on assets(7)(2)——
Retiree contributions——23
Company contributions181633
Benefits paid(146)(44)(5)(6)
Assets at end of year$606$576$—$—

We currently expect to contribute $16 to our pension plans and $3 to our postretirement medical and life insurance benefit plans during 2025.

Funded status. The funded status of a plan refers to the difference between its assets and its obligations. The following table shows the funded status of our plans.

Pension BenefitsMedical and LifeInsurance Benefits
April 30,2023202420232024
Assets$606$576$—$—
Obligations(731)(679)(40)(36)
Funded status$(125)$(103)$(40)$(36)

The funded status is recorded on the accompanying consolidated balance sheets as follows:

Pension BenefitsMedical and LifeInsurance Benefits
April 30,2023202420232024
Other assets$17$32$—$—
Accounts payable and accrued expenses(8)(8)(3)(3)
Accrued pension and other postretirement benefits(134)(127)(37)(33)
Net liability$(125)$(103)$(40)$(36)
Accumulated other comprehensive income (loss), before tax:
Net actuarial gain (loss)$(192)$(166)$(1)$2
Prior service credit (cost)(4)(4)21
$(196)$(170)$1$3

The following table compares our pension plans whose accumulated benefit obligations exceed their assets with our pension plans whose assets exceed their accumulated benefit obligations.

AccumulatedBenefit ObligationPlan Assets
April 30,2023202420232024
Plans with accumulated benefit obligation in excess of assets$(131)$(124)$—$—
Plans with assets in excess of accumulated benefit obligation(524)(487)606576
Total$(655)$(611)$606$576

The following table compares our pension plans whose projected benefit obligations exceed their assets with our pension plans whose assets exceed their projected benefit obligations.

ProjectedBenefit ObligationPlan Assets
April 30,2023202420232024
Plans with projected benefit obligation in excess of assets$(190)$(135)$48$—
Plans with assets in excess of projected benefit obligation(541)(544)558576
Total$(731)$(679)$606$576

As noted above, we have no assets set aside for the postretirement medical or life insurance benefit plans.

Pension cost. The following table shows the components of the pension cost recognized during each of the last three years. The amount for each year includes amortization of the prior service cost/credit and net actuarial loss/gain included in accumulated other comprehensive loss as of the beginning of the year.

Pension Benefits
202220232024
Service cost$26$20$18
Interest cost223234
Expected return on assets(45)(43)(40)
Amortization of:
Prior service cost (credit)111
Net actuarial loss (gain)2396
Settlement charge1229—
Net cost$39$48$19

We determine the expected return on plan assets by applying our long-term rate of return assumption to the market-related value of plan assets, adjusted by earnings on contributions and benefit payments expected to be made during the year. We calculate the market-related value of plan assets by amortizing actual versus expected returns over five years.

We amortize prior service costs and net actuarial gains or losses on straight-line basis over the average remaining service period of the employees expected to receive benefits under the plan. However, for net actuarial gains or losses, we use a corridor approach that amortizes them only to the extent the gain or loss exceeds 10% of the greater of the projected benefit obligation or market-related value of plan assets.

The settlement charges recognized during 2022 and 2023 were triggered by fiscal year-to-date lump-sum payments under certain pension plans surpassing total annual service and interest cost for those plans.

Other postretirement benefits cost. The following table shows the components of the postretirement medical and life insurance benefits cost that we recognized during each of the last three years.

Medical and Life Insurance Benefits
202220232024
Service cost$1$1$—
Interest cost112
Amortization of:
Prior service cost (credit)(2)——
Net actuarial loss (gain)1——
Net cost$1$2$2

We amortize prior service costs and net actuarial gains or losses on straight-line basis over the average remaining service period of the employees expected to receive benefits under the plan.

Other comprehensive income (loss). We recognize prior service cost/credit and net actuarial loss/gain in other comprehensive income or loss (OCI) during the period in which they arise. These amounts are later amortized from accumulated OCI into pension and other postretirement benefit cost over future periods as described above. The following table shows the pre-tax effect of these amounts on OCI during each of the last three years.

Pension BenefitsMedical and LifeInsurance Benefits
202220232024202220232024
Net actuarial gain (loss)$62$(29)$20$5$2$3
Amortization reclassified to earnings:
Prior service cost (credit)111(2)——
Net actuarial loss (gain)353861——
Net amount recognized in OCI$98$10$26$4$2$3

Assumptions and sensitivity. We use various assumptions to determine the obligations and cost related to our pension and other postretirement benefit plans. The weighted-average assumptions used in computing benefit plan obligations as of the end of the last two years were as follows:

Pension BenefitsMedical and LifeInsurance Benefits
2023202420232024
Discount rate4.91%5.70%4.86%5.66%
Rate of salary increase4.00%4.00%n/an/a
Interest crediting rate3.69%4.79%n/an/a

The weighted-average assumptions used in computing benefit plan cost during each of the last three years were as follows:

Pension BenefitsMedical and LifeInsurance Benefits
202220232024202220232024
Discount rate for service cost3.36%4.52%4.98%3.49%4.50%5.02%
Discount rate for interest cost2.34%4.12%4.79%2.27%3.96%4.78%
Rate of salary increase4.00%4.00%4.00%n/an/an/a
Interest crediting rate3.06%3.06%3.69%n/an/an/a
Expected return on plan assets6.25%6.25%6.50%n/an/an/a

We determine the assumed discount rates using a yield curve based on the interest rates of high-quality debt securities with maturities corresponding to the expected timing of our benefit payments. We measure the service cost and interest cost components by applying the specific spot rates along the yield curve used to measure the benefit obligation at the beginning of the period.

The assumed rate of salary increase reflects the expected average annual increase in salaries as a result of inflation, merit increases, and promotions over the service period of the plan participants.

The assumed interest crediting is based on the greater of the average yield on 30-year Treasury bonds or the minimum rate specified in the applicable pension plan.

The expected return on plan assets represents the long-term rate of return that we assume will be earned over the life of the pension assets. The assumption reflects expected capital market returns for each asset class, which are based on historical returns, adjusted for the expected effects of diversification.

The assumed health care cost trend rates as of the end of the last two years were as follows:

Medical and LifeInsurance Benefits
20232024
Health care cost trend rate assumed for next year7.23%7.13%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)4.50%4.50%
Year that the rate reaches the ultimate trend rate20322032

Savings plans. We also sponsor various defined contribution benefit plans that together cover substantially all U.S. employees. Employees can make voluntary contributions in accordance with their respective plans, which include a 401(k) tax deferral option. We match a percentage of each employee's contributions in accordance with plan terms. We expensed $13, $14, and $14 for matching contributions during 2022, 2023, and 2024, respectively.

International plans. The information presented above for defined benefit plans and defined contribution benefit plans reflects amounts for U.S. plans only. Information about similar international plans is not presented due to immateriality.

  1. Stock-Based Compensation

The Brown-Forman 2022 Omnibus Compensation Plan (Plan) is our incentive compensation plan, designed to reward participants (including eligible executive officers, other employees, and non-employee directors) for company performance. Under the Plan, we can grant stock-based incentive awards for up to 12,412,433 shares of common stock to eligible participants until July 28, 2032. As of April 30, 2024, awards for approximately 11,269,000 shares remain available for issuance under the Plan. We try to limit the source of shares delivered to participants under the Plan to treasury shares that we purchase from time to time on the open market (in connection with a publicly announced share repurchase program), in private transactions, or otherwise.

Awards granted under the Plan include stock-settled stock appreciation rights (SSARs), performance-based restricted stock units (PBRSUs), time-based restricted stock units (RSUs), and deferred stock units (DSUs).

SSARs. We grant SSARs at an exercise price equal to the closing market price of the underlying stock on the grant date. SSARs become exercisable after three years from the first day of the fiscal year of grant and generally are exercisable for seven years after that date. The following table presents information about SSARs outstanding as of April 30, 2024, and for the year then ended.

Number ofSSARs(in thousands)Weighted-AverageExercise Priceper SSARWeighted-AverageRemainingContractualTerm (years)AggregateIntrinsic Value
Outstanding at April 30, 20234,010$51.76
Granted33669.69
Exercised(568)37.85
Forfeited or expired(28)64.63
Outstanding at April 30, 20243,750$55.374.6$12
Exercisable at April 30, 20242,617$48.543.4$12

We use the Black-Scholes pricing model to calculate the grant-date fair value of a SSAR. The weighted-average grant-date fair values and related valuation assumptions for the SSARS granted during each of the last three years were as follows:

202220232024
Grant-date fair value$16.61$20.67$21.69
Valuation assumptions:
Expected term (years)7.07.07.0
Risk-free interest rate1.0%2.7%4.1%
Expected volatility24.1%24.8%25.0%
Expected dividend yield1.0%1.0%1.2%

The expected term is based on past exercise experience for similar awards. The risk-free interest rate is based on zero-coupon U.S. Treasury rates as of the date of grant. Expected volatility and dividend yield are based on historical data, with consideration of other factors when applicable.

PBRSUs. The PBRSUs vest at the end of a three-year performance period that begins on the first day of the fiscal year of grant. For PBRSU granted in fiscal 2022 and 2023, performance is measured in full by comparing the three-year cumulative total shareholder return (TSR) of our Class B common stock to the three-year cumulative TSR of the companies in the Standard & Poor’s Consumer Staples Index (the peer group). Beginning with PBRSUs granted in fiscal 2024, performance is measured based in part (50%) on our TSR compared to the TSR of the peer group and in part (50%) on our adjusted operating income growth compared to the adjusted operating income growth of the peer group over the three-year performance period. At the end of the performance period, the number of PBRSUs is adjusted for performance, and then adjusted upward to account for dividends paid during the second and third years of the performance period. The resulting PBRSUs are then converted to common shares.

The following table presents information about PBRSUs outstanding as of April 30, 2024, and for the year then ended.

Number ofPBRSUs(in thousands)Weighted-AverageFair Value atGrant Date
Outstanding at April 30, 2023289$76.33
Granted209$75.70
Adjusted for performance and dividends(38)$73.56
Converted to common shares(41)$73.56
Forfeited(6)$77.12
Outstanding at April 30, 2024413$76.53

For the portion of the PBRSUs based on adjusted operating income performance, we calculate the grant-date fair value using the closing market price on the underlying stock at the date of grant, discounted for dividends that are not paid on the PBRSUs during the first year of the performance period.

For the portion of the PBRSUs based on TSR, we calculate the grant-date fair value using a Monte Carlo simulation model. The following table shows the assumptions used in the Monte Carlo simulation model to value the awards granted during each of the last three fiscal years.

202220232024
Valuation assumptions:
Risk-free interest rate0.3%2.8%4.6%
Expected volatility29.1%29.8%22.2%
Expected dividend yield1.0%1.0%1.2%
Remaining performance period (years) as of grant date2.82.82.8

RSUs. Beginning in fiscal 2024, we grant time-based restricted stock units (RSUs) to certain non-executive employees. Each RSU represents the right to receive one share of Class B common stock. The RSUs vest in three equal amounts at the end of each of the subsequent three fiscal years. Outstanding RSUs are credited with dividend-equivalent RSUs when dividends are paid on our common stock. The grant-date fair value of an RSU is the closing market price of the underlying stock on the grant date. The following table presents information about RSUs outstanding as of April 30, 2024, and for the year then ended.

Number ofRSUs(in thousands)Weighted-AverageFair Value atGrant Date
Outstanding at April 30, 2023—$—
Granted89$68.89
Additions for dividend equivalents1$69.41
Forfeited(3)$69.17
Outstanding at April 30, 202487$68.88

DSUs. DSUs are granted to our non-employee directors. Each DSU represents the right to receive one share of common stock based on the closing price of the shares on the date of grant. Outstanding DSUs are credited with dividend-equivalent DSUs when dividends are paid on our common stock. Each annual grant vests after one year. DSUs are paid out in shares after the completion of a director's tenure on the board plus a six-month waiting period. The director may elect to receive the distribution either in a single lump sum or in ten equal annual installments. As of April 30, 2024, there were approximately 181,000 outstanding DSUs, of which approximately 159,000 were vested.

The grant-date fair value of a DSU is the closing market price of the underlying stock on the grant date. The weighted average grant-date fair values for these awards granted during each of the last three years were as follows:

202220232024
Grant-date fair value$67.35$72.10$71.23

Additional information. The pre-tax stock-based compensation expense and related deferred income tax benefits recognized during the last three fiscal years were as follows:

202220232024
Pre-tax compensation expense$15$18$25
Deferred tax benefit233

As of April 30, 2024, there was $14 of total unrecognized compensation cost related to non-vested stock-based awards. That cost is expected to be recognized over a weighted-average period of 1.6 years. Further information related to our stock-based awards for the last three years is as follows:

202220232024
Intrinsic value of SSARs exercised$23$19$12
Fair value of shares vested764
Excess tax benefit from exercise / vesting of awards642
  1. Income Taxes

We incur income taxes on the earnings of our U.S. and foreign operations. The following table, based on the locations of the taxable entities from which sales were derived (rather than the location of customers), presents the U.S. and foreign components of our income before income taxes:

202220232024
United States$954$841$917
Foreign160176381
$1,114$1,017$1,298

The income shown above was determined according to GAAP. Because those standards sometimes differ from the tax rules used to calculate taxable income, there are differences between (a) the amount of taxable income and pretax financial income for a year, and (b) the tax bases of assets or liabilities and their amounts as recorded in our financial statements. As a result, we recognize a current tax liability for the estimated income tax payable on the current tax return, deferred tax liabilities (tax on income that will be recognized on future tax returns), and deferred tax assets (tax from deductions that will be recognized on future tax returns) for the estimated effects of the differences mentioned above.

Total income tax expense for a year includes the tax associated with the current tax return (current tax expense) and the change in the net deferred tax asset or liability (deferred tax expense). Our total income tax expense for each of the last three years was as follows:

202220232024
Current:
U.S. federal$205$157$150
Foreign644681
State and local183425
287237256
Deferred:
U.S. federal1(4)16
Foreign(9)6(5)
State and local(3)(5)7
(11)(3)18
$276$234$274

Our consolidated effective tax rate usually differs from current statutory rates due to the recognition of amounts for events or transactions with no tax consequences. The following table reconciles our effective tax rate to the federal statutory tax rate in the United States:

Percent of Income Before Taxes
202220232024
U.S. federal statutory rate21.0%21.0%21.0%
State taxes, net of U.S. federal tax benefit1.0%2.5%1.3%
Income taxed at other than U.S. federal statutory rate1.3%3.0%0.5%
Prior intercompany sales taxed at higher than current U.S. federal statutory rate2.0%1.0%—%
Tax benefit from foreign-derived sales(1.8%)(3.0%)(1.7)%
Business divestitures—%—%(0.7)%
Adjustments related to prior years0.7%(0.5%)—%
Excess tax benefits from stock-based awards(0.5%)(0.3%)(0.1)%
Tax rate changes0.4%—%0.4%
Valuation allowance—%(1.3%)0.1%
Other, net0.7%0.6%0.4%
Effective rate24.8%23.0%21.2%

Deferred tax assets and liabilities as of the end of each of the last two years were as follows:

April 30,20232024
Deferred tax assets:
Postretirement and other benefits$75$65
Accrued liabilities and other3547
Inventories2626
Lease liabilities2327
Loss and credit carryforwards6265
Total deferred tax assets221230
Valuation allowance(14)(16)
Total deferred tax assets, net of valuation allowance207214
Deferred tax liabilities:
Intangible assets(323)(295)
Property, plant, and equipment(98)(93)
Right-of-use assets(23)(27)
Derivative instruments(3)(3)
Equity method investments—(37)
Other(17)(5)
Total deferred tax liabilities(464)(460)
Net deferred tax liability$(257)$(246)

Details of the loss and credit carryforwards and related valuation allowances as of the end of each of the last two years are as follows:

April 30, 2023 · April 30, 2024
Gross Amount · Deferred Tax Asset · Valuation Allowance · Gross Amount · Deferred Tax Asset · Valuation Allowance
U.S.$111$20$(6)$110$381$(7)
Foreign21642(8)161272(9)
$327$62$(14)$271$65$(16)

1 As of April 30, 2024, the deferred tax asset amount includes credit carryforwardsof $28 that do not expire and loss and credit carryforwards of$10 that expire in varying amounts from 2025 to 2039.

2 As of April 30, 2024, the deferred tax asset includes loss carryforwardsof $25 that do not expire and $2 that expire in varying amounts over the next 10 years.

As of April 30, 2024, we had approximately $1,909 of undistributed earnings from our foreign subsidiaries ($1,617 at April 30, 2023). These earnings have been previously subject to tax, primarily as a result of the 2017 Tax Cuts and Jobs Act. Historically, we have asserted that the undistributed earnings of our foreign subsidiaries are reinvested indefinitely outside the United States. We continue to maintain indefinite reinvestment assertions for most undistributed earnings of our foreign subsidiaries, and no deferred taxes have been provided on the earnings. For undistributed earnings not considered permanently reinvested, deferred tax liabilities have been provided for any applicable income taxes and withholding taxes payable in various countries, which are not significant. We have also asserted that other outside basis differences related to our foreign subsidiaries are reinvested indefinitely and that the determination of any unrecognized deferred tax liabilities is not practicable due to the complexities in the calculations. The other outside basis differences relate primarily to differences between U.S. GAAP and tax basis that arose through purchase accounting. These basis differences could reverse through sales of foreign subsidiaries or other transactions, none of which are considered probable as of April 30, 2024.

At April 30, 2024, we had $14 of gross unrecognized tax benefits, $11 of which would reduce our effective income tax rate if recognized. A reconciliation of the beginning and ending unrecognized tax benefits follows:

202220232024
Unrecognized tax benefits at beginning of year$12$14$21
Additions for tax positions provided in prior periods281
Additions for tax positions provided in current period232
Decreases for tax positions provided in prior years——(3)
Settlements of tax positions in the current period——(3)
Lapse of statutes of limitations(2)(4)(4)
Unrecognized tax benefits at end of year$14$21$14

We file federal income tax returns in the United States and also file tax returns in various state, local and foreign jurisdictions. The major jurisdictions where we are subject to examination by tax authorities include the United States, Australia, Brazil, Germany, Korea, Mexico, Netherlands, and the United Kingdom. We have tax years open for examination from 2013 and forward. Various tax examinations are currently in progress in the United States, for both federal and states, and in certain foreign jurisdictions. In the United States, we are participating in the Internal Revenue Service's Compliance Assurance Program for our fiscal 2024 tax year.

We believe there will beno material change in our gross unrecognized tax benefits in the next 12 months.

  1. Acquisitions

On November 3, 2022, we acquired the Gin Mare and Gin Mare Capri brands through our purchase of 100% of the equity interests of Gin Mare Brand, S.L.U., a Spanish company, and Mareliquid Vantguard, S.L.U., a Spanish company (the “Gin Mare acquisition”). The acquisition was accounted for as a business combination. The purchase price of the Gin Mare acquisition was $523, which consisted of $468 in cash paid at the acquisition date plus contingent consideration of $55. The purchase price for the Gin Mare acquisition decreased by $1 as a result of certain fair value adjustments to the contingent consideration made during the first half of fiscal 2024, which were primarily a result of changes in the discount rates used to calculate the fair value as of the acquisition date.

We have allocated the purchase price of the Gin Mare acquisition based on management’s estimates and independent valuations as follows:

Prior Allocation1AdjustmentsFinal Allocation
Trademarks and brand names (indefinite-lived)$307$(24)$283
Goodwill28917306
Total assets596(7)589
Deferred tax liabilities72(6)66
Net assets acquired$524$(1)$523

1 As reported in Note 12 to our consolidated financial statements in our 2023 Form 10-K.

The adjustments to the prior Gin Mare purchase price allocation reflect revised valuations for the trademarks and brand names, which were driven by an increase in the discount rates used to calculate fair values as of the acquisition date, partially offset by higher projections of future cash flows. The Gin Mare purchase price allocation was finalized during the second quarter of fiscal 2024.

The contingent consideration of $55 reflects the estimated fair value, at the acquisition date, of contingent future cash payments of up to €90 to the sellers under an “earn-out” provision of the acquisition agreement. We determined the estimated fair value of the contingent consideration using a Monte Carlo simulation, which requires the use of assumptions, such as projected future net sales, discount rates, and volatility rates.

Any contingent consideration earned by the sellers will be payable in cash no earlier than July 2024 and no later than July 2027, depending on when the sellers choose to exercise the right to receive the payment. The amount payable will depend on the achievement of net sales targets for Gin Mare for the latest fiscal year completed prior to the date of exercise by the sellers. The possible payments range from zero to €90 (approximately $89 as of the acquisition date).

At the acquisition date, we also entered into a supply agreement with the sellers for the production and supply of Gin Mare products to us, at market terms, for an initial period of 10 years (subject to subsequent renewal periods).

On January 5, 2023, we acquired the Diplomático and Botucal rum brands through our purchase of (i)100% of the equity interests of (a) International Rum and Spirits Distributors Unipessoal, Lda., a Portuguese company, (b) Diplomático Branding Unipessoal Lda., a Portuguese company, (c) International Bottling Services, S.A., a Panamanian corporation, and (d) International Rum & Spirits Marketing Solutions, S.L., a Spanish company; and (ii) certain assets of Destilerias Unidas Corp. (the “Diplomático acquisition”). The acquisition was accounted for as a business combination. The purchase price of the Diplomático acquisition consisted of cash of $723 (net of a post-closing working capital adjustment of $4).

We have allocated the purchase price of the Diplomático acquisition based on management’s estimates and independent valuations as follows:

Prior Allocation1AdjustmentsFinal Allocation
Accounts receivable$11$—$11
Inventories36(2)34
Other current assets25—25
Property, plant, and equipment38—38
Trademarks and brand names (indefinite-lived)312(29)283
Goodwill36323386
Other assets2—2
Total assets787(8)779
Accounts payable and accrued expenses13114
Deferred tax liabilities45(5)40
Other liabilities2—2
Total liabilities60(4)56
Net assets acquired$727$(4)$723

1 As reported in Note 12 to our consolidated financial statements in our 2023 Form 10-K.

The adjustments to the prior Diplomático purchase price allocation reflect revised valuations for the trademarks and brand names, which were driven by an increase in the discount rates used to calculate fair values as of the acquisition date, partially offset by higher projections of future cash flows. The adjustments also reflect certain other immaterial net working capital adjustments. The Diplomático purchase price allocation was finalized during the third quarter of fiscal 2024.

At the acquisition date, we also entered into a supply agreement with the sellers for their production and supply of rum to us, at market terms, for an initial period of 10 years (subject to subsequent renewal periods).

The amounts allocated to trademarks and brand names for each acquisition were estimated using the relief-from-royalty method, which requires the use of significant assumptions, such as net sales, discount rates, and royalty rates.

Goodwill is calculated as the excess of the purchase price over the fair value of the net identifiable assets acquired. The goodwill recorded for each acquisition is primarily attributable to the value of leveraging our distribution network and brand-building expertise to grow sales of the acquired brands. For the Gin Mare acquisition, we expect none of the goodwill of $306 to be deductible for tax purposes. For the Diplomático acquisition, we expect $108 of the goodwill of $386 to be deductible for tax purposes.

In connection with the acquisitions, we recognized transaction expenses of $55 during fiscal 2023. The following table shows the classification of the transaction expenses in the accompanying consolidated statement of operations.

2023
Selling, general, and administrative expenses$11
Other expense (income), net44
Total transaction expenses$55

The transaction expenses largely reflect payments made to terminate certain distribution contracts related to the acquired brands.

  1. Divestitures

On November 1, 2023, we sold the Finlandia vodka business to Coca-Cola HBC AG for $196 in cash. The net carrying amount of the related business assets and liabilities included in the sale was $100, consisting largely of goodwill and other intangible assets. As a result of the sale, we recognized a pre-tax gain of $92 during fiscal 2024, calculated as follows:

Cash proceeds$196
Net carrying amount of assets and liabilities sold(100)
Amounts reclassified from AOCI:
Cumulative translation losses(30)
Net investment hedge gain (Note 15)26
Pre-tax gain on divestiture of Finlandia$92

On April 30, 2024, we sold the Sonoma-Cutrer wine business to The Duckhorn Portfolio, Inc.(“Duckhorn”) in exchange for an ownership percentage of 21.4% in Duckhorn and cash of $50. The net carrying amount of the related business assets and liabilities included in the sale was $142 and consisted of the following:

Inventories$56
Property, plant, and equipment83
Goodwill18
Other assets1
Total assets sold158
Accounts payable and accrued expenses3
Deferred tax liabilities12
Other liabilities1
Total liabilities sold16
Net assets sold$142

As a result of the sale, we recognized a pre-tax gain of $175 during the fourth quarter of fiscal 2024, calculated as follows:

Cash proceeds$50
Fair value of equity interest in Duckhorn267
Total consideration received317
Net carrying amount of assets and liabilities sold(142)
Pre-tax gain on divestiture of Sonoma-Cutrer$175

We entered into transition services agreements in connection with the divestitures of both the Finlandia and Sonoma-Cuter businesses.

  1. Derivative Financial Instruments and Hedging Activities

We are subject to market risks, including the effect of fluctuations in foreign currency exchange rates, commodity prices, and interest rates. We use derivatives to help manage financial exposures that occur in the normal course of business. We formally document the purpose of each derivative contract, which includes linking the contract to the financial exposure it is designed to mitigate. We do not hold or issue derivatives for trading or speculative purposes.

We use currency derivative contracts to limit our exposure to the foreign currency exchange risk that we cannot mitigate internally by using netting strategies. We designate most of these contracts as cash flow hedges of forecasted transactions (expected to occur within three years). We record all changes in the fair value of cash flow hedges in accumulated other comprehensive income (AOCI) until the underlying hedged transaction occurs, when we reclassify that amount into earnings.

Some of our currency derivatives are not designated as hedges because we use them to partially offset the immediate earnings impact of changes in foreign currency exchange rates on existing assets or liabilities. We immediately recognize the change in fair value of these contracts in earnings.

We had outstanding currency derivatives, related primarily to our euro, British pound, and Australian dollar exposures, with notional amounts for all hedged currencies totaling $747 and $566 at April 30, 2023 and 2024, respectively. The maximum term of outstanding derivative contracts was 24 months at both April 30, 2023 and 2024.

We also use foreign currency-denominated debt to help manage our foreign currency exchange risk. We designate a portion of those debt instruments as net investment hedges, which are intended to mitigate foreign currency exposure related to non-U.S. dollar net investments in certain foreign subsidiaries. Any change in value of the designated portion of the hedging instruments is recorded in AOCI, offsetting the foreign currency translation adjustment of the related net investments that is also recorded in AOCI. The amount of foreign currency-denominated debt designated as net investment hedges was $495 and $497 as of April 30, 2023 and 2024, respectively.

At inception, we expect each financial instrument designated as a hedge to be highly effective in offsetting the financial exposure it is designed to mitigate, and we assess hedge-effectiveness continually. If we determine that any financial instruments designated as hedges are no longer highly effective, we discontinue hedge accounting for those instruments.

We use forward purchase contracts with suppliers to protect against corn price volatility. We expect to take physical delivery of the corn underlying each contract and use it for production over a reasonable period of time. Accordingly, we account for these contracts as normal purchases rather than as derivative instruments.

During fiscal 2024, we reclassified $26 of gains on net investment hedges from AOCI to earnings in connection with the divestiture of Finlandia (Note 14).

The following table presents the pre-tax impact that changes in the fair value of our derivative instruments and non-derivative hedging instruments had on AOCI and earnings during each of the last three years:

Classification in Statement of Operations202220232024
Currency derivatives designated as cash flow hedges:
Net gain (loss) recognized in AOCIn/a$76$4$11
Net gain (loss) reclassified from AOCI into earningsSales53712
Net gain (loss) reclassified from AOCI into earningsOther income (expense), net2——
Interest rate derivatives designated as cash flow hedges:
Net gain (loss) recognized in AOCIn/a—(1)—
Currency derivatives not designated as hedging instruments:
Net gain (loss) recognized in earningsSales12(1)—
Net gain (loss) recognized in earningsOther income (expense), net5168
Foreign currency-denominated debt designated as net investment hedge:
Net gain (loss) recognized in AOCIn/a7833
Net gain (loss) reclassified from AOCI to earningsGain on business divestitures——26
Total amounts presented in the accompanying consolidated statements of operations for line items affected by the net gains (losses) shown above:
Sales5,0815,3725,328
Other income (expense), net(59)(119)(24)

We expect to reclassify $7 of deferred net gains on cash flow hedges recorded in AOCI as of April 30, 2024, to earnings during fiscal 2025. This reclassification would offset the anticipated earnings impact of the underlying hedged exposures. The actual amounts that we ultimately reclassify to earnings will depend on the exchange rates in effect when the underlying hedged transactions occur.

The following table presents the fair values of our derivative instruments as of April 30, 2023 and 2024:

Balance Sheet ClassificationDerivative AssetsDerivative Liabilities
Designated as cash flow hedges:
Currency derivativesOther current assets$20$(11)
Currency derivativesOther assets5(1)
Currency derivativesAccrued expenses—(1)
Currency derivativesOther liabilities—(1)
Not designated as hedges:
Currency derivativesOther current assets3—
Designated as cash flow hedges:
Currency derivativesOther current assets11(2)
Currency derivativesOther assets1(1)
Not designated as hedges:
Currency derivativesAccrued expenses—(1)

The fair values reflected in the above table are presented on a gross basis. However, as discussed further below, the fair values of those instruments subject to net settlement agreements are presented on a net basis in our balance sheets.

In our statements of cash flows, we classify cash flows related to cash flow hedges in the same category as the cash flows from the hedged items.

Credit risk. We are exposed to credit-related losses if the counterparties to our derivative contracts default. This credit risk is limited to the fair value of the contracts. To manage this risk, we contract only with major financial institutions that have earned investment-grade credit ratings and with whom we have standard International Swaps and Derivatives Association (ISDA) agreements that allow for net settlement of the derivative contracts. Also, we have established counterparty credit guidelines that we monitor regularly. Based on our most recent assessment. we consider our counterparty credit risk to be low.

Our derivative instruments require us to maintain a specific level of creditworthiness, which we have maintained. If our creditworthiness were to fall below that level, then the counterparties to our derivative instruments could request immediate payment or collateralization for derivative instruments in net liability positions. The aggregate fair value of all derivatives with creditworthiness requirements that were in a net liability position was $1 and $1 at April 30, 2023 and 2024, respectively.

Offsetting. As noted above, our derivative contracts are governed by ISDA agreements that allow for net settlement of derivative contracts with the same counterparty. It is our policy to present the fair values of current derivatives (that is, those with a remaining term of 12 months or less) with the same counterparty on a net basis in our balance sheets. Similarly, we present the fair values of noncurrent derivatives with the same counterparty on a net basis. We do not net current derivatives with noncurrent derivatives in our balance sheets.

The following table summarizes the gross and net amounts of our derivative contracts:

Gross Amounts of Recognized Assets (Liabilities)Gross Amounts Offset inBalance SheetNet Amounts Presented in Balance SheetGross Amounts Not Offset in Balance SheetNet Amounts
Derivative assets$28$(12)$16$(1)$15
Derivative liabilities(14)12(2)1(1)
Derivative assets12(3)9—9
Derivative liabilities(4)3(1)—(1)

No cash collateral was received or pledged related to our derivative contracts as of April 30, 2023 or 2024.

  1. Fair Value Measurements

The following table summarizes the assets and liabilities measured or disclosed at fair value on a recurring basis:

20232024
April 30,CarryingAmountFairValueCarryingAmountFairValue
Assets:
Cash and cash equivalents$374$374$446$446
Currency derivatives161699
Liabilities:
Currency derivatives2211
Contingent consideration63636969
Short-term borrowings235235428428
Long-term debt (including current portion)2,6782,5562,6722,468

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We categorize the fair values of assets and liabilities into three levels based on the assumptions (inputs) used to determine those values. Level 1 provides the most reliable measure of fair value, while Level 3 generally requires significant management judgment. The three levels are:

Level 1– Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2– Observable inputs other than those included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in inactive markets, or other inputs that are observable or can be derived from or corroborated by observable market data.

Level 3– Unobservable inputs supported by little or no market activity.

We determine the fair values of our currency derivatives (forward contracts) using standard valuation models. The significant inputs used in these models, which are readily available in public markets or can be derived from observable market transactions, include the applicable spot exchange rates, forward exchange rates, and interest rates. These fair value measurements are categorized as Level 2 within the valuation hierarchy.

We determine the fair value of long-term debt primarily based on the prices at which identical or similar debt has recently traded in the market and also considering the overall market conditions on the date of valuation. These fair value measurements are categorized as Level 2 within the valuation hierarchy.

The fair values of cash, cash equivalents, and short-term borrowings approximate the carrying amounts due to the short maturities of these instruments.

We determine the fair value of our contingent consideration liability using a Monte Carlo simulation model, which requires the use of Level 3 inputs, such as projected future net sales, discount rates, and volatility rates. Changes in any of these Level 3 inputs could result in material changes to the fair value of the contingent consideration and could materially impact the amount of non-cash expense (or income) recorded each reporting period.

The following table shows the changes in our contingent consideration liability:

Balance as of April 30, 2022$—
Acquisition of business (Note 13)56
Foreign currency translation adjustment7
Balance as of April 30, 202363
Purchase accounting adjustment (Note 13)(1)
Change in fair value19
Foreign currency translation adjustment(2)
Balance as of April 30, 2024$69

1 Classified as “other expense (income), net” in the accompanying consolidated statement of operations.

See Note 13 for additional information about the contingent consideration liability.

We measure some assets and liabilities at fair value on a nonrecurring basis. That is, we do not measure them at fair value on an ongoing basis, but we do adjust them to fair value in some circumstances (for example, when we determine that an asset is impaired). We recognized non-cash impairment charges of $52 and $96 related to the Finlandia brand name during fiscal 2022 and 2023, respectively. The impairment charges were based on the estimated fair value of the brand name, which we determined using the relief-from-royalty method. As discussed in Note 13, we also used the relief-from-royalty method to determine fair values in connection with our accounting for business combinations. The fair value measurements determined using this method are categorized as Level 3 within the valuation hierarchy. No other material nonrecurring fair value measurements were required during the periods presented in these financial statements.

  1. Leases

We enter into lease arrangements, which we use primarily for office space, vehicles, and land. Substantially all of our leases are operating leases. Our finance leases are not material.

We record lease liabilities and right-of-use (ROU) assets on our balance sheet for leases with terms exceeding 12 months. We do not record lease liabilities or ROU assets for short-term leases. The amounts recorded for lease liabilities and ROU assets are based on the estimated present value, as of the lease commencement date, of the future payments to be made over the lease term. We calculate the present value using our incremental borrowing rate that corresponds to the term of the lease. We include the effect of an option to renew or terminate a lease in the lease term when it is reasonably certain that we will exercise the option.

Some of our leases contain non-lease components (e.g., maintenance or other services) in addition to lease components. We have elected the practical expedient not to separate the non-lease components from the lease components.

The following table shows information about our leases as of the end of the last two years:

Balance Sheet Classification · April 30,2023 · April 30,2024
Right-of-use assetsOther assets$84$96
Lease liabilities:
CurrentAccounts payable and accrued expenses$22$24
Non-currentOther liabilities6373
Total$85$97
Weighted-average discount rate3.3%4.2%
Weighted-average remaining term5.1 years5.1 years

The following table shows information about the effects of leases during each of the last three years:

202220232024
Total lease cost1$38$38$51
Cash paid for amounts included in the measurement of lease liabilities2252529
Right-of-use assets obtained in exchange for new lease liabilities352938

1 Consists primarily of operating lease cost. Other components of lease cost were not material.

2 Classified within operating activities in the accompanying consolidated statements of cash flows.

The following table includes a maturity analysis of future (undiscounted) lease payments and a reconciliation of those payments to the lease liabilities recorded on our balance sheet as of April 30, 2024:

April 30,2024
2025$27
202623
202719
202814
202911
Thereafter13
Total lease payments107
Less: Present value discount(10)
Lease liabilities$97
  1. Other Comprehensive Income

The following table presents the components of net other comprehensive income (loss) during each of the last three years:

Pre-TaxTaxNet
Currency translation adjustments:
Net gain (loss) on currency translation$(42)$(18)$(60)
Reclassification to earnings———
Other comprehensive income (loss), net(42)(18)(60)
Cash flow hedge adjustments:
Net gain (loss) on hedging instruments76(17)59
Reclassification to earnings1(7)1(6)
Other comprehensive income (loss), net69(16)53
Postretirement benefits adjustments:
Net actuarial gain (loss) and prior service cost67(16)51
Reclassification to earnings234(8)26
Other comprehensive income (loss), net101(24)77
Total other comprehensive income (loss), net$128$(58)$70
Currency translation adjustments:
Net gain (loss) on currency translation$135$—$135
Reclassification to earnings———
Other comprehensive income (loss), net135—135
Cash flow hedge adjustments:
Net gain (loss) on hedging instruments3(1)2
Reclassification to earnings1(37)8(29)
Other comprehensive income (loss), net(34)7(27)
Postretirement benefits adjustments:
Net actuarial gain (loss) and prior service cost(26)6(20)
Reclassification to earnings238(9)29
Other comprehensive income (loss), net12(3)9
Total other comprehensive income (loss), net$113$4$117
Currency translation adjustments:
Net gain (loss) on currency translation$(16)$(1)$(17)
Reclassification to earnings34610
Other comprehensive income (loss), net(12)5(7)
Cash flow hedge adjustments:
Net gain (loss) on hedging instruments11(2)9
Reclassification to earnings1(12)3(9)
Other comprehensive income (loss), net(1)1—
Postretirement benefits adjustments:
Net actuarial gain (loss) and prior service cost22(5)17
Reclassification to earnings26(2)4
Other comprehensive income (loss), net28(7)21
Total other comprehensive income (loss), net$15$(1)$14

1 For 2022, $(2) of the pre-tax amount of $(7) is classified in other expense (income) in the accompanying consolidated statements of operations. Otherwise, the pre-tax amount for each year is classified as sales.

2 Pre-tax amount is classified as non-operating postretirement expense in the accompanying consolidated statements of operations.

3 Pre-tax amount is classified in gain on business divestitures in the accompanying consolidated statements of operations.

  1. Supplemental Information

The following table presents net sales by geography:

202220232024
United States$1,917$1,968$1,889
Mexico178244290
Germany228239263
Australia219221204
United Kingdom218207185
Other1,1731,3491,348
Total net sales$3,933$4,228$4,178

Net sales are attributed to countries based on where customers are located. See Note 9 for additional information about net sales, including net sales by product category.

Our two largest customers accounted for 14% and 12% of consolidated net sales in 2022;14% and 12% of consolidated net sales in 2023; and 13% and 11% of consolidated net sales in 2024.

The net book value of property, plant, and equipment located outside the United States was $204 and $255 as of April 30, 2023 and 2024, respectively. Other long-lived assets located outside the United States are not significant.

We have concluded that our business constitutes a single operating segment.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.